Cingulate logo

Cingulate share price today

(CING)

Cingulate share price is $4.86 & ₹414.06 as on 25 Dec 2024, 2.30 'hrs' IST

$4.86

0.1

(2.1%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Cingulate share price in Dollar and Rupees. Guide to invest in Cingulate from India. Also see the sentimental analysis on Indian investors investing in Cingulate. Get details on the Indian mutual funds that are investing in Cingulate. Get Analyst recommendations and forecasts along with all the Cingulate's financials.

Cingulate share price movements

  • Today's Low: $4.69
    Today's High: $5.09

    Day's Volatility :7.83%

  • 52 Weeks Low: $1.80
    52 Weeks High: $152.40

    52 Weeks Volatility :98.82%

Cingulate Returns

PeriodCingulate IncIndex (Russel 2000)
3 Months
-5.45%
0.0%
6 Months
-30.65%
0.0%
1 Year
-89.85%
0.0%
3 Years
-99.24%
-21.1%

Cingulate Key Statistics

in dollars & INR

Previous Close
$4.76
Open
$4.8
Today's High
$5.0934
Today's Low
$4.6946
Market Capitalization
$15.6M
Today's Volume
$149.5K
52 Week High
$152.4
52 Week Low
$1.8001
Revenue TTM
$0.0
EBITDA
$-15.6M
Earnings Per Share (EPS)
$-43.22
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-273.82%

How to invest in Cingulate from India?

It is very easy for Indian residents to invest directly in Cingulate from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cingulate stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cingulate or CING on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cingulate or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cingulate shares which would translate to 0.175 fractional shares of Cingulate as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cingulate, in just a few clicks!

Returns in Cingulate for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cingulate investment value today

Current value as on today

₹12,389

Returns

₹87,611

(-87.61%)

Returns from Cingulate Stock

₹89,850 (-89.85%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Cingulate

1%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Cingulate on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 1% more investors are searching Cingulate in the last 30 days versus the previous period.

Global Institutional Holdings in Cingulate

  • UBS Group AG

    0.43%

  • Commonwealth Equity Services Inc

    0.35%

  • Bank of America Corp

    0.06%

  • Virtu Financial LLC

    0.05%

  • Tower Research Capital LLC

    0.05%

  • FMR Inc

    0.01%

Analyst Recommendation on Cingulate

Buy

    70%Buy

    30%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Cingulate(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
3
3
3
Sell
0
0
0

Analyst Forecast on Cingulate

What analysts predicted

Upside of 894.51%

Current:

$4.86

Target:

$48.33

Insights on Cingulate

  • Price Movement

    In the last 7 days, CING stock has moved up by 18.5%
  • CING vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 106.7%
  • CING vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 124.4%

Cingulate Technicals Summary

Sell

Neutral

Buy

Cingulate is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Cingulate Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cingulate Inc
11.47%
-30.65%
-89.85%
-99.24%
-99.54%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-3.72%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cingulate Inc
NA
NA
NA
-9.5
-2.74
-1.04
NA
6.82
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cingulate Inc
Buy
$15.6M
-99.54%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Cingulate

Organization
Cingulate
Employees
13
CEO
Dr. Shane J. Schaffer Pharm.D.
Industry
Miscellaneous

Management People of Cingulate

NameTitle
Dr. Shane J. Schaffer Pharm.D.
CEO & Chairman of the Board
Dr. Laurie A. Myers M.B.A., Ph.D.
Executive VP & COO
Dr. Matthew N. Brams M.D.
Executive VP & Chief Medical Officer
Ms. Jennifer L. Callahan CPA
Senior VP, CFO & Secretary
Dr. Raul R. Silva M.D.
Executive VP & Chief Science Officer
Thomas Dalton
Vice President of Investor & Public Relations

Important FAQs about investing in Cingulate from India :

What is Cingulate share price today?

Cingulate share price today stands at $4.86, Open: $4.80 ; Previous Close: $4.76 ; High: $5.09 ; Low: $4.69 ; 52 Week High: $152.40 ; 52 Week Low: $1.80. The stock opens at $4.80, after a previous close of $4.76. The stock reached a daily high of $5.09 and a low of $4.69, with a 52-week high of $152.40 and a 52-week low of $1.80.

Can Indians buy Cingulate shares?

Yes, Indians can invest in the Cingulate (CING) from India.

With INDmoney, you can buy Cingulate at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Cingulate at zero transaction cost.

How can I buy Cingulate shares from India?

It is very easy to buy Cingulate from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cingulate be purchased?

Yes, you can buy fractional shares of Cingulate with INDmoney app.

What are the documents required to start investing in Cingulate stocks?

To start investing in Cingulate, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Cingulate

Today’s highest price of Cingulate (CING) is $5.09.

Today’s lowest price of Cingulate (CING) is $4.69.

What is today's market capitalisation of Cingulate

Today's market capitalisation of Cingulate CING is 15.6M

What is the 52 Week High and Low Range of Cingulate

  • 52 Week High

    $152.40

  • 52 Week Low

    $1.80

What are the historical returns of Cingulate?

  • 1 Month Returns

    11.47%

  • 3 Months Returns

    -30.65%

  • 1 Year Returns

    -89.85%

  • 5 Years Returns

    -99.54%

Who is the Chief Executive Officer (CEO) of Cingulate

Dr. Shane J. Schaffer Pharm.D. is the current Chief Executive Officer (CEO) of Cingulate.